0001209191-18-026617.txt : 20180427
0001209191-18-026617.hdr.sgml : 20180427
20180427164200
ACCESSION NUMBER: 0001209191-18-026617
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170614
FILED AS OF DATE: 20180427
DATE AS OF CHANGE: 20180427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trainor-Degirolamo Sheldon
CENTRAL INDEX KEY: 0001708966
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 18784692
MAIL ADDRESS:
STREET 1: C/O ATHENEX, INC. 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2017-06-14
2017-06-21
0
0001300699
Athenex, Inc.
ATNX
0001708966
Trainor-Degirolamo Sheldon
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
1
0
0
0
Stock Option (Right to Buy)
11.00
2017-06-14
4
A
0
19500
0.00
A
2027-06-14
Common Stock
19500
19500
D
The option vests in four equal annual installments beginning on June 14, 2018.
This amendment is being filed to correct a typographical error in the acquisition date of the option referenced above and related information including the option's exercise and expiration dates and the date of earliest transaction in the Form 4.
/s/ Teresa Bair, Attorney-in-Fact
2018-04-27